Submitted by dcc on Fri, 2018-04-13 09:45 Study Title: A Randomized Phase II Study of Nivolumab After Combined Modality Therapy (CMT) in High Risk Anal CancerCIRB: Adult CIRB - Late Phase EmphasisLead Group: ECOG-ACRINStatus: ActiveReview Status: Available to Open
